TrialThe Lancet. Haematology2021

Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study.

Toby A Eyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.